Jonathan Phillips - Aug 12, 2025 Form 4 Insider Report for STREAMLINE HEALTH SOLUTIONS INC. (STRM)

Role: Director
Signature: /s/ Jonathan Phillips
Stock symbol: STRM
Transactions as of: Aug 12, 2025
Transactions value $: $0
Form type: 4
Date filed: 8/14/2025, 01:02 PM
Previous filing: Jul 23, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
PHILLIPS JONATHAN R	Director	1212 PORT LANE, SARASOTA	/s/ Jonathan Phillips	2025-08-14	0001326105

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STRM	Common Stock, $0.01 par value	Disposed to Issuer		-96.3K	-100%		0	Aug 12, 2025	Direct	F1
transaction	STRM	Common Stock, $0.01 par value	Disposed to Issuer		-4.83K	-100%		0	Aug 12, 2025	Refer to footnote	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STRM	Warrant (right to buy)	Disposed to Issuer		-2.99K	-100%		0	Aug 12, 2025	Common Stock, $0.01 par value	2.99K	$5.85	Direct	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jonathan Phillips is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2025, by and among the Issuer, Mist Holding Co. ("Parent"), and MD BE Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer, effective as of August 12, 2025, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock, par value $0.01 per share, of the Company ("Common Stock") issued and outstanding as of immediately prior to the Effective Time was canceled and converted into the right to receive $5.34 in cash, without interest (the "Merger Consideration").
F2	Includes 4,833 shares owned by spouse.
F3	The Issuer effected a 1-for-15 reverse stock split of its common stock on October 4, 2024. The number of securities reported on this Form 4 has been adjusted to reflect the reverse stock split.
F4	Pursuant to the terms of the Merger Agreement, at the Effective Time, each warrant to purchase shares of Common Stock (each, a "Company Warrant") that was outstanding and unexercised and had a per share exercise price that was less than the Merger Consideration was canceled and converted into the right to receive (i) a cash payment equal to (A) the number of shares of Common Stock subject to the Company Warrant immediately prior to the Effective Time multiplied by (B) the excess, if any, of (x) the Merger Consideration over (y) the exercise price per share of Common Stock of such Company Warrant, less applicable withholding taxes. Each Company Warrant that was outstanding and unexercised with a per share exercise price that was equal to or greater than the Merger Consideration was canceled for no consideration.